Organization | Norton Healthcare

Norton Healthcare Report issue

Academic/Hospital Phase 2 Phase 4

Founded: Louisville KY United States (1886)

Organization Overview

First Clinical Trial

2004

NCT00513617

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Now

Alternative names

Jeffrey L Gum MD | Jeffrey L Stimac MD | Joseph M. Flynn, D.O., MPH | Norton Healthcare | Norton Leatherman Spine Center

Active Ingredients

Drugs in Phase 4 Trials (4)

albuterol (proventil) (1 trial)

bupivacaine (Exparel) (1 trial)

dronabinol (marinol) (1 trial)

ropivacaine (naropin) (1 trial)

Drugs in Phase 2 Trials (4)

arginine (1 trial)

bevacizumab (avastin) (1 trial)

COVID-19 convalescent plasma (1 trial)

mannitol (Osmitrol) (1 trial)

Drugs in Other Trials (5)

acetylcysteine (mucomyst) (1 trial)

fish oil (Omegavan) (1 trial)

glutathione (Furadantin) (1 trial)

norethindrone (1 trial)

vitamin c (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Anemia (Phase 2)

Anemia, Sickle Cell (Phase 2)

Infections (Phase 2)

Necrosis (Phase 2)

Pain, Postoperative (Phase 4)

Status Asthmaticus (Phase 4)

Overview

Highest Phase: Phase 4
# of Trials: 9
# of Trial APIs: 13